Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion type Assertion NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_head.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion wasGeneratedBy ECO_0000203 NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_provenance.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion wasDerivedFrom befree-20140225 NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_provenance.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion SIO_000772 20404253 NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_provenance.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion evidence source_evidence_literature NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_provenance.
- NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_assertion description "[Compared with nontransgenic mice, HO-1 transgenic HF mice exhibited significantly (P<0.05) improved postinfarction survival (94% versus 57%) and less LV dilatation (end-diastolic volume, 46+/-8 versus 85+/-32 microL), mechanical dysfunction (ejection fraction, 65+/-9% versus 49+/-16%), hypertrophy (LV/tibia length 4.4+/-0.4 versus 5.2+/-0.6 mg/mm), interstitial fibrosis (11.2+/-3.1% versus 18.5+/-3.5%), and oxidative stress (3-fold reduction in tissue malondialdehyde).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665582.RAdUA3iQ66JXTU5CfEyFLOeMNelPxsoVijLROK_mHuqDI130_provenance.